Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced 2023-08-25 10:06
Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy 2023-08-25 08:15
Antheia Achieves Major Commercial Milestone 2023-08-25 08:01
YS Biopharma Announces Purchase of Shares by Company Officers 2023-08-25 04:15
Ping An Health announces 2023 interim results 2023-08-24 20:58
Vittra APS Unique composite by FGM is appointed as a solution to a clinical problem by the renowned agency Dental Advisor 2023-08-24 18:00
MRI Software's first 'Voice of the Strata Manager' report reveals unseen pressures of high-demand real estate industry job 2023-08-24 13:02
Everest Medicines Announces Interim Results for First Half of 2023 2023-08-24 08:15
Salvia BioElectronics: First-Ever Patient Treated with Breakthrough Neuromodulation Solution for Severe Migraine and Cluster Headache in Australia 2023-08-24 05:45
Optum Applauded by Frost & Sullivan for Advancing the Use of Real-World Evidence by Life Sciences Companies and for Its Market-leading Position 2023-08-23 22:00
Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit 2023-08-23 20:06
Innovent Announces 2023 Interim Results and Business Updates 2023-08-23 19:38
Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US 2023-08-23 18:07
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company 2023-08-23 17:40
USANA Philippines Celebrates Legacy of Wellness Empowerment With Enterprise Asia Linchpin of Asia Awards 2023 2023-08-23 17:06
Leading by Inspiration: KPJ Tawakkal KL Specialist Hospital Triumphs with Asia Pacific Enterprise Award for its Exceptional Brand 2023-08-23 15:18
MGI Partners with NGeneBio to Advance Precision Medicine 2023-08-23 09:00
Lynk Pharmaceuticals Announces Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Ankylosing Spondylitis 2023-08-23 08:00
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results 2023-08-22 22:00
Paradigm Therapeutics Acquires Late Stage "Breakthrough Therapy" Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB) 2023-08-22 21:13
1 48 49 50 51 52 490